Johnson & Johnson Shares Outstanding 2012-2026 | JNJ

Johnson & Johnson shares outstanding for the quarter ending March 31, 2026 were 2.445B, a 0.88% increase year-over-year.

  • Johnson & Johnson 2025 shares outstanding were 2.429B, a 0% decline from 2024.
  • Johnson & Johnson 2024 shares outstanding were 2.429B, a 5.12% decline from 2023.
  • Johnson & Johnson 2023 shares outstanding were 2.56B, a 3.89% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Johnson & Johnson Shares Outstanding 2012-2026 | JNJ

  • Johnson & Johnson 2025 shares outstanding were 2.429B, a 0% decline from 2024.
  • Johnson & Johnson 2024 shares outstanding were 2.429B, a 5.12% decline from 2023.
  • Johnson & Johnson 2023 shares outstanding were 2.56B, a 3.89% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B